Neel Mistry on Muck Rack

Neel Mistry

Boston
As seen in: 2 Minute Medicine, MDPI, The Toronto Star, NewsBreak, St. Catharines Standard, Physician's Weekly, Welland Tribune, Academic Radiology
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Neel

Contact Neel, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Paclitaxel-coated devices do not reduce rates of major amputations in chronic limb-threatening ischemia

|
By Neel Mistry
| 2 Minute Medicine Verified
1. All-cause mortality and reduction in major amputations were similar between groups. 2. The rate of target vessel reintervention was similar in paclitaxel-coated and uncoated devices groups at 5 years. Evidence Rating Level: 1 (Excellent) Study Rundown: Drug-coated devices are commonly used in coronary and peripheral artery interventions, but their impact on amputation risk in peripheral artery disease remains unclear.
Open in Who Shared Issue with article?

Clopidogrel monotherapy is superior to aspirin for secondary prevention in coronary artery disease

|
By Neel Mistry
| 2 Minute Medicine Verified
1. Major adverse cardiovascular and cerebrovascular events were significantly reduced with clopidogrel compared to aspirin alone. 2. There was no significant difference between groups regarding risk of bleeding. Evidence Rating Level: 1 (Excellent) Study Rundown: Aspirin has been recommended to be used indefinitely in patients with coronary artery disease (CAD). However, the comparative efficacy of clopidogrel versus aspirin monotherapy has not been fully evaluated.
Open in Who Shared Issue with article?

Influenza vaccination improves survival and reduces readmissions in patients hospitalized for acute heart failure

|
By Neel Mistry
| 2 Minute Medicine Verified
1. All-cause mortality and hospital readmissions were significantly decreased with influenza vaccination compared to usual care. 2. Significantly fewer adverse events were reported in the influenza vaccination group. Evidence Rating Level: 1 (Excellent) Study Rundown: Influenza vaccination is recommended to reduce morbidity and mortality for patients with chronic conditions, such as heart failure.
Open in Who Shared Issue with article?
See all 378 articles
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified